subject area of
- 1-deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases Academic Article
- A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A Academic Article
- Advances and challenges in hemophilic arthropathy Academic Article
- An alternative extrinsic pathway of human-blood coagulation Academic Article
- Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis Academic Article
- Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor Academic Article
- Aptamer BAX499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein Academic Article
- Asymptomatic liver disease in haemophiliacs Academic Article
- Concentrates of clotting-factor IX Academic Article
- Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease Academic Article
- DDAVP in haemophilia Academic Article
- Deficiency of protein-C inhibitor in combined factor-V-VIII deficiency disease Academic Article
- Development of factor VIII antibody in haemophilic monozygotic twins. Academic Article
- Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: Studies of spatial dynamics of fibrin clot formation in hemophilia A Academic Article
- Enhanced factor VIII activity in von Willebrand's disease Academic Article
- Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A Academic Article
- Factor VIII/von Willebrand factor Academic Article
- Hemophilia care in Italy Academic Article
- Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection Academic Article
- Human protein-C and thromboembolic disease Academic Article
- Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant Academic Article
- Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation Academic Article
- Inhibition of fibrinolysis by recombinant factor viia in plasma from patients with severe hemophilia a Academic Article
- Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma Academic Article
- Interaction of factor VIII antigen in hemophilic plasmas with human antibodies to factor VIII Academic Article
- Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants Academic Article
- Molecular immunology of factor VIII Academic Article
- Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (tafi) by thrombin Academic Article
- Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors Academic Article
- Prevalence and risk factors for hypertension in hemophilia Academic Article
- Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase b that unites the pathways of coagulation and fibrinolysis Academic Article
- Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII Academic Article
- Studies on human protein-C inhibitor in normal and factor-V/VIII deficient plasmas Academic Article
- The defective down regulation of fibrinolysis in haemophilia a can be restored by increasing the tafi plasma concentration Academic Article
- Vascular remodeling underlies rebleeding in hemophilic arthropathy Academic Article
- [Factor VIII inhibitors][Article in Italian] Academic Article